Mitoxantrone-<wbr/>d<sub>8</sub>

Mitoxantrone-d8

CAT N°: 29414
Price:

457.00 388.45

Mitoxantrone-d8 is intended for use as an internal standard for the quantification of mitoxantrone (Item No. 14842) by GC- or LC-MS. Mitoxantrone is an inhibitor of DNA topoisomerase II? and HIV-1 integrase (IC50s = 5.3 and 3.8 ?M, respectively).{23705,23704} It intercalates into DNA in a cell-free assay when used at a concentration of 2 µM, as well as inhibits DNA synthesis and induces DNA-protein crosslinks in vitro in a concentration-dependent manner.{23705,23708} Mitoxantrone inhibits the growth of K562 leukemia and K562-derived etoposide-resistant K/VP.5 cells (IC50s = 0.42 and 1.68 µM, respectively).{23705} It also inhibits the membrane fusion of a mixed population of HEK293T cells expressing either angiotensin-converting enzyme 2 (ACE2) or the extracellular domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein, also known as surface glycoprotein.{67150} Mitoxantrone (0.2 µM) inhibits the entry of SARS-CoV-2 into Vero E6 cells. Formulations containing mitoxantrone have been used in the treatment of cancer and multiple sclerosis.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl-1,1,2,2-d4)amino]ethyl]amino]-9,10-anthracenedione
  • Correlated keywords
    • deuterated deuterium GCMS LCMS NCI 301739 NCI301739 Novantrone NSC 301739 NSC301739 HIV1 K-562 HEK-293T ACE-2 OVID19 SARSCoV2 SARS-CoV2 SARSCoV
  • Product Overview:
    Mitoxantrone-d8 is intended for use as an internal standard for the quantification of mitoxantrone (Item No. 14842) by GC- or LC-MS. Mitoxantrone is an inhibitor of DNA topoisomerase II? and HIV-1 integrase (IC50s = 5.3 and 3.8 ?M, respectively).{23705,23704} It intercalates into DNA in a cell-free assay when used at a concentration of 2 µM, as well as inhibits DNA synthesis and induces DNA-protein crosslinks in vitro in a concentration-dependent manner.{23705,23708} Mitoxantrone inhibits the growth of K562 leukemia and K562-derived etoposide-resistant K/VP.5 cells (IC50s = 0.42 and 1.68 µM, respectively).{23705} It also inhibits the membrane fusion of a mixed population of HEK293T cells expressing either angiotensin-converting enzyme 2 (ACE2) or the extracellular domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein, also known as surface glycoprotein.{67150} Mitoxantrone (0.2 µM) inhibits the entry of SARS-CoV-2 into Vero E6 cells. Formulations containing mitoxantrone have been used in the treatment of cancer and multiple sclerosis.

We also advise you